Eli Lilly and Company (LLY)
US listed · Healthcare · Drug Manufacturers - General
This page tracks Eli Lilly and Company (LLY) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews LLY against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Jun 28, 2026LLY presents a solid long setup anchored by exceptional fundamentals: +128.8% EPS growth, +47.4% revenue growth, a 43.41% 1Y CAGR, and a near-52-week high price reflecting sustained institutional demand. Recent catalysts — EMA backing for Jaypirca, positive Phase 3 CLL trial results, a Leerink price target upgrade, and a new BioArctic collaboration — provide a meaningful news-driven tailwind. The composite pre-screen score of 1.99 is marginal, but the fundamental and news quality substantially overpower the weak quantitative score; the primary caution is the RSI at 72.35 (overbought territory) and a slightly negative MACD histogram, which suggest near-term consolidation risk but not a trend reversal.
No buy/sell call, target or confidence is shown: tracked against what stocks did next, they have not predicted direction.
LLY — Frequently Asked Questions
Is Eli Lilly and Company (LLY) a buy right now?
StockTracker AI does not rate LLY a buy or a sell. As of June 28, 2026 its AI analysis sets out the evidence and the risks instead. Tracked against what stocks did next, its buy/sell calls have not predicted direction, so they are not shown. This is informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is the AI price forecast for LLY?
StockTracker AI generates a probability-weighted 30-day price forecast for LLY — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze LLY?
Each scan screens LLY on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for LLY — free.
Add LLY to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for LLY
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →